QuidelOrtho Corp
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
QDEL$11.52-4.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of (Loss) Income
(In millions, except per share data)
| Fiscal Year Ended | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Total revenues | $2,997.8 | $3,266.0 | $1,698.6 |
| Cost of sales, excluding amortization of intangibles | 1,503.4 | 1,330.0 | 420.3 |
| Selling, marketing and administrative | 763.2 | 621.0 | 239.6 |
| Research and development | 246.8 | 190.5 | 95.7 |
| Amortization of intangible assets | 204.8 | 132.5 | 27.4 |
| Acquisition and integration costs | 113.4 | 136.0 | 9.6 |
| Other operating expenses | 27.1 | 12.3 | — |
| Operating income | 139.1 | 843.7 | 906.0 |
| Interest expense, net | 147.6 | 75.7 | 5.8 |
| Loss on extinguishment of debt | — | 24.0 | — |
| Other expense (income), net | 20.6 | 8.1 | (0.1) |
| (Loss) income before income taxes | (29.1) | 735.9 | 900.3 |
| (Benefit from) provision for income taxes | (19.0) | 187.2 | 196.1 |
| Net (loss) income | $(10.1) | $548.7 | $704.2 |
| Basic (loss) earnings per share | $(0.15) | $9.66 | $16.74 |
| Diluted (loss) earnings per share | $(0.15) | $9.56 | $16.43 |
| Weighted-average shares outstanding - basic | 66.8 | 56.8 | 42.1 |
| Weighted-average shares outstanding - diluted | 66.8 | 57.4 | 42.9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.